We are live on
!
Find out more
Federated Hermes Portfolio holdings
AUM
$69.6B
1-Year Est. Return
42.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.69%
1 Year Est. Return
+42.52%
3 Year Est. Return
+132.48%
5 Year Est. Return
+152.58%
10 Year Est. Return
+652.43%
AUM
$53.1B
AUM Growth
+$6.76B
(+15%)
Cap. Flow
+$2.33B
Cap. Flow
% of AUM
4.39%
Top 10 Holdings %
Top 10 Hldgs %
14.65%
Holding
2,220
New
169
Increased
729
Reduced
1,033
Closed
165
Avg Time Held
21.7
quarters
Top 10 Avg Time Held
6.6
quarters
Top 20 Avg Time Held
9.9
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zscaler
ZS
|
+$222M |
| 2 |
Palantir
PLTR
|
+$221M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$213M |
| 4 |
FirstEnergy
FE
|
+$189M |
| 5 |
Broadcom
AVGO
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$383M |
| 2 |
Philip Morris
PM
|
+$280M |
| 3 |
Entergy
ETR
|
+$207M |
| 4 |
Paychex
PAYX
|
+$206M |
| 5 |
Gilead Sciences
GILD
|
+$201M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.81% |
| 2 | Healthcare | 14.57% |
| 3 | Financials | 13.43% |
| 4 | Industrials | 10.29% |
| 5 | Consumer Discretionary | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1901
BioAge Labs
BIOA
$291M
| $4.12K | ﹤0.01% |
+998
| New | +$4.02K |
2025 Q2
0 quarters
|
|
1902
SmartFinancial
SMBK
$855M
| $4.12K | ﹤0.01% |
+122
| New | +$3.77K |
2025 Q2
0 quarters
|
|
1903
Bloomin' Brands
BLMN
$736M
| $4.09K | ﹤0.01% |
475
-712
| -60% | -$5.72K |
2025 Q1
1 quarter
|
|
1904
Arlo Technologies
ARLO
$1.33B
| $4.09K | ﹤0.01% |
241
-88
| -27% | -$1.13K |
2023 Q2
8 quarters
|
|
1905
Penguin Solutions Inc
PENG
$3.91B
| $4.08K | ﹤0.01% |
206
-1,137
| -85% | -$20.6K |
2025 Q1
1 quarter
|
|
1906
M-tron Industries
MPTI
$307M
| $4.07K | ﹤0.01% |
97
-110
| -53% | -$5.3K |
2024 Q4
2 quarters
|
|
1907
Kulicke & Soffa
KLIC
$4.81B
| $3.98K | ﹤0.01% |
115
-1,264
| -92% | -$41.1K |
2024 Q1
5 quarters
|
|
1908
People Inc
PPLI
$3.04B
| $3.92K | ﹤0.01% |
105
-23
| -18% | -$831 |
2022 Q4
10 quarters
|
|
1909
Carriage Services
CSV
$535M
| $3.8K | ﹤0.01% |
83
-103
| -55% | -$4.3K |
2024 Q4
2 quarters
|
|
1910
Honda
HMC
$42.4B
| $3.78K | ﹤0.01% |
131
| – | – |
2020 Q2
20 quarters
|
|
1911
CBL Properties
CBL
$1.5B
| $3.76K | ﹤0.01% |
148
+96
| +185% | +$2.37K |
2024 Q3
3 quarters
|
|
1912
Team
TISI
$120M
| $3.71K | ﹤0.01% |
204
| – | – |
2024 Q3
3 quarters
|
|
1913
Investar Holding Corp
ISTR
$397M
| $3.71K | ﹤0.01% |
192
-31
| -14% | -$572 |
2024 Q3
3 quarters
|
|
1914
Q32 Bio
QTTB
$248M
| $3.65K | ﹤0.01% |
2,452
-30
| -1% | -$51 |
2024 Q3
3 quarters
|
|
1915
iRadimed
IRMD
$1.12B
| $3.65K | ﹤0.01% |
61
| – | – |
2015 Q3
39 quarters
|
|
1916
Wave Life Sciences
WVE
$682M
| $3.6K | ﹤0.01% |
553
-55,305
| -99% | -$365K |
2024 Q4
2 quarters
|
|
1917
PACS Group
PACS
$6.86B
| $3.48K | ﹤0.01% |
269
-40
| -13% | -$416 |
2024 Q4
2 quarters
|
|
1918
CuriosityStream
CURI
$166M
| $3.29K | ﹤0.01% |
585
| – | – |
2024 Q4
2 quarters
|
|
1919
Univest Financial
UVSP
$1.13B
| $3.24K | ﹤0.01% |
108
+20
| +23% | +$582 |
2025 Q1
1 quarter
|
|
1920
Groupon
GRPN
$758M
| $3.18K | ﹤0.01% |
95
+15
| +19% | +$383 |
2020 Q4
18 quarters
|
|
1921
TScan Therapeutics
TCRX
$16.1M
| $3.16K | ﹤0.01% |
2,181
-1
| -0% | -$1 |
2025 Q1
1 quarter
|
|
1922
Barclays
BCS
$76.6B
| $3.12K | ﹤0.01% |
168
-58
| -26% | -$959 |
2024 Q4
2 quarters
|
|
1923
Outset Medical
OM
$76.1M
| $3.11K | ﹤0.01% |
+162
| New | +$2.53K |
2025 Q2
0 quarters
|
|
1924
Mitek Systems
MITK
$799M
| $3.11K | ﹤0.01% |
+314
| New | +$2.82K |
2025 Q2
0 quarters
|
|
1925
Zurn Elkay Water Solutions
ZWS
$7.72B
| $3.11K | ﹤0.01% |
85
-1,695
| -95% | -$58.3K |
2024 Q4
2 quarters
|
|
Similar funds
Federated Hermes's Q2 2025 Portfolio in Review
As of Q2 2025, Federated Hermes held 2,220 positions worth $53.1B, up 15% from $46.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
Federated Hermes deployed $2.33B of net new capital in Q2 2025, opening 169 new positions and adding to 729 existing holdings. Its largest new stake was Genuine Parts: 882,160 shares worth $107M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $383M trimmed.
- Federated Hermes's largest Q2 2025 buy was Genuine Parts: 882,160 shares worth $107M.
- Federated Hermes added most to Zscaler in Q2 2025, an estimated $222M increase.
- Federated Hermes's biggest Q2 2025 reduction was Bristol-Myers Squibb, cutting an estimated $383M.
- Federated Hermes fully exited Regulus Therapeutics in Q2 2025, selling an estimated $39.2M.
- Federated Hermes's ten largest holdings make up 15% of its $53.1B portfolio in Q2 2025.
- Federated Hermes opened 169 new positions and closed 165 in Q2 2025.
- Federated Hermes's portfolio value rose 15% quarter-over-quarter to $53.1B.
Based on Federated Hermes's 13F filing for Q2 2025, filed 13 Aug 2025.